Showing results (481-490 of 526) with videos related to

Sort By:
Pageof 53
Science Advances|January 21, 2022
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemiaCuijuan Han, Alireza Khodadadi-Jamayran, Adam H Lorch, et al.
Clinical Cardiology|May 13, 2025
Lipid-Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-Blind, Parallel, Multicenter, Phase 3 Clinical TrialYou-Jeong Ki, Weon Kim, Ki Hong Lee, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 25, 2023
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertensionKi-Chul Sung, Soon Jun Hong, Moo-Yong Rhee, et al.
Molecular Cancer Therapeutics|December 21, 2025
Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignanciesElspeth M Beauchamp, Atul Jain, Matt Clutter, et al.
JAMA|June 17, 2020
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical TrialByeong-Keuk Kim, Sung-Jin Hong, Yun-Hyeong Cho, et al.
Korean Circulation Journal|February 7, 2022
Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO TrialYong-Joon Lee, Yongsung Suh, Jung-Sun Kim, et al.
JACC. Cardiovascular Interventions|February 19, 2021
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial InfarctionSeung-Jun Lee, Jae Young Cho, Byeong-Keuk Kim, et al.
Clinical Therapeutics|February 10, 2016
Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical StudyHan Cheol Lee, Sang-Rok Lee, Kyoo-Rok Han, et al.
Korean Circulation Journal|November 25, 2017
Bioresorbable Vascular Scaffold Korean Expert Panel ReportJung Min Ahn, Duk Woo Park, Sung Jin Hong, et al.
American Heart Journal|April 3, 2026
Optimal antiplatelet strategy in patients with advanced chronic kidney disease undergoing drug-eluting stent implantation: Design and rationale of the randomized ADAPT-CKD trialIn Tae Jin, Sang-Hyup Lee, Kyeong Ho Yun, et al.
Pageof 53